Profile
Deya Corzo worked as an Executive Director-Medical at Celgene Corp.
from 2012 to 2014.
She then worked as SVP-Research & Development, Head-Therapeutic Area at uniQure NV from 2014 to 2017.
From 2017 to 2018, she served as Chief Medical Officer at Sojournix, Inc. and from 2018 to 2021, she worked as Chief Medical Officer at Sigilon Therapeutics, Inc. Dr. Corzo holds a doctorate degree from Universidad Industrial de Santander.
Former positions of Deya Corzo
| Companies | Position | End |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/07/2021 |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Sojournix, Inc. operates in the healthcare industry focusing on biotechnology business. It develops medicines for women’s health and endocrine disorders. The company was founded by Scott L. Rakestraw and Daniel Grau in 2016 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 31/12/2017 |
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
| CELGENE | Corporate Officer/Principal | 31/12/2013 |
Training of Deya Corzo
| Universidad Industrial de Santander | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| UNIQURE N.V. | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Sojournix, Inc. operates in the healthcare industry focusing on biotechnology business. It develops medicines for women’s health and endocrine disorders. The company was founded by Scott L. Rakestraw and Daniel Grau in 2016 and is headquartered in Waltham, MA. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Deya Corzo
